Changeflow GovPing

What do you monitor?

Curated feeds for your role. Pick your area and get exactly the sources you need.

Recent changes

Favicon for changeflow.com

Patent Application: Culture Medium Production Using Microbial Co-Hydrolysis

The USPTO has published a patent application (US20260085281A1) detailing a method for producing culture medium through microbial co-hydrolysis of plant proteins. The application, filed on April 10, 2025, aims to improve soil and cultivation effects using waste seasoning.

Routine Notice Pharmaceuticals
Favicon for changeflow.com

Patent Application for Modified Microorganisms Consuming Xylose

The USPTO has published a patent application (US20260085280A1) for methods of modifying microorganisms to increase xylose consumption. The application, filed by MARA RENEWABLES CORPORATION, details processes for enhancing microbial growth on hemicellulosic carbohydrates.

Routine Guidance Pharmaceuticals
Favicon for changeflow.com

Corynebacterium Mutant Strain for Enhanced L-Arginine or L-Citrulline Productivity

The USPTO has published a patent application by Daesang Corporation for a Corynebacterium mutant strain designed for enhanced L-arginine or L-citrulline productivity. The application details a method for producing these amino acids using the modified strain, which exhibits increased activity in the L-arginine biosynthesis pathway.

Routine Notice Pharmaceuticals
Favicon for changeflow.com

Genetically Modified Clostridium Acetobutylicum for Lignocellulosic Biomass

The USPTO has published a patent application (US20260085278A1) detailing genetically modified Clostridium acetobutylicum strains designed for efficient growth on lignocellulosic biomass. The application, filed by Institut National des Sciences Appliquees de Toulouse, describes overexpressing specific operons to enhance biomass conversion for producing bulk chemicals like ethanol and butanol.

Routine Notice Pharmaceuticals
Favicon for changeflow.com

Patent Application for Microorganism and Ergothioneine Production

The USPTO has published a patent application (US20260085277A1) from Kureha Corporation detailing a novel microorganism and a method for producing ergothioneine. The application includes specific microorganism accessions and CPC classifications related to biotechnology and chemical synthesis.

Routine Notice Pharmaceuticals
Favicon for changeflow.com

Patent Application for Mycelium Substrate Preparation

The USPTO has published a new patent application (US20260085276A1) detailing means and methods for preparing a mycelium-colonized substrate. The application, filed on September 25, 2023, describes a method involving incubating a substrate with synthetic granulometry regulators and a solid-state mycelium bioreactor.

Routine Notice Pharmaceuticals
Favicon for changeflow.com

Patent Application for On-Board Lysis Capsule in Fluidic Cartridge

The USPTO has published a patent application (US20260085275A1) for an on-board lysis capsule designed for fluidic cartridges. The capsule contains beads and magnetic elements for cell lysis and may include an internal control for assay validation. The application was filed by Gen-Probe Incorporated.

Routine Notice Pharmaceuticals
Favicon for changeflow.com

Patent Application for Fermentation Process Standardization

The USPTO has published a patent application (US20260085274A1) from Precision Fermentation, Inc. The application details methods and systems for standardizing fermentation processes, including constructing baseline databases and initiating new process instances. This is a new patent application filing.

Routine Notice Pharmaceuticals
Favicon for changeflow.com

Electroporation Apparatus and Methods Patent Application

The USPTO has published a patent application (US20260085268A1) filed by MaxCyte, Inc. on September 6, 2023. The application describes an apparatus and methods for electroporation of cells, including safety features like an emergency stop button. This is a new patent application and does not impose new regulatory requirements.

Routine Notice Healthcare
Favicon for changeflow.com

USPTO patent application for bioprocess on cell cultures

The USPTO has published a patent application (US20260085266A1) detailing a method for performing a bioprocess on liquid immune or naive cell cultures. The application, filed on December 13, 2022, describes an integrated bioprocessing system with preconfigurable cartridges for cell therapy.

Routine Notice Healthcare

Showing 4111–4120 of 32,994 changes

1 410 411 412 413 414 3300

Get alerts when regulations change

Weekly digest. AI-summarized, no noise.

Free. Unsubscribe anytime.